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ABSTRACT
Background: It has not been clear about how often the patient should have esophago-gastroduodenoscopy 
(EGD )screening for esophageal varices (EV) detection and there is only some data that demonstrates the 
correlation between the degree of EV and non-endoscopic variables. It is assumed that the presence of EV 
detected though examination of serum albumin level may trim down the unnecessary endoscopy. This study was 
aimed to recognize the correlation between albumin level and the degree of EV in patients with liver cirrhosis.
Method: A retrospective analysis was performed for 61 patients with liver cirrhosis who had EGD at Sanglah 
hospital between January and December 2008. Spearman test was used to analyze the correlation between 
albumin level and the degree of EV. 
Results: There were 61 patients of 45 (73.8%) male and 16 (26.2%) female. The range age of patients was 
13–77 years (average 49.98 ± 1.62 years). Serum albumin level ranged between 1.10-3.60 mg/dL, the average 
value was 2.21 ± 0.451 mg/dL. We also found 8 (13.1%) patients without  EV, 14 (23.0%) patients with EV grade 
I, 21 (34.4%) patients with grade II and 18 (29.5%) patients with grade III. A negative correlation was found 
between serum albumin level and the degree of EV (r = - 0.587; p = 0.000, p < 0.01).
Conclusion: Serum albumin level can predict the presence and the degree of EV in patients with liver cirrhosis. 
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ABSTRAK
Latar belakang: Belum jelas seberapa sering pasien harus melakukan esofago-gastroduodenoskopi (EGD) 
untuk skrining varises, dan hanya sedikit data yang menunjukkan hubungan derajat varises dan variabel non-
endoskopik. Dugaan adanya varises esofagus (VE) melalui kadar albumin serum dapat mengurangi endoskopi 
yang tidak perlu. Tujuan penelitian ini untuk mengetahui korelasi antara albumin dan derajat VE pada pasien 
sirosis hati.
Metode: Suatu analisis retrospektif dilakukan pada 61 pasien sirosis hati yang melakukan pemeriksaan EGD 
di Rumah Sakit Sanglah pada bulan Januari-Desember 2008. Tes Spearman digunakan untuk menganalisis 
korelasi antara albumin dan derajat VE.
Hasil: Terdapat 61 pasien terdiri dari 45 (73,8%) laki-laki, dan 16 (26,2%) perempuan, dengan usia antara 
13–77 tahun dengan rerata 49,98 ± 1,62 tahun. Kadar albumin antara 1,10-3,60 mg/dL, rerata 2,21 ± 0,45 
mg/dL. Ditemukan pula berturut-turut pasien tanpa VE 8 (13.1%), derajat I 14 (23.0%), derajat II 21 (34.4%), 
dan derajat III 18 (29,5%) orang. Terdapat korelasi negatif antara albumin serum dan derajat VE (r = - 0,587; 
p = 0,000; p < 0,01).
Kesimpulan: Albumin serum dapat memprediksi ada dan derajat VE pada pasien sirosis hati.
Kata kunci: albumin, derajat VE, sirosis hati
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INTRODUCTION 
Esophageal varices (EV) are a major complication of 
liver cirrhosis due to portal hypertension. It is assumed 
that the prevalence is approximately 50% of patients 
with cirrhosis and the rate of incidence is assumed to 
be increasing at 5% per year. Moreover, the progression 
of EV from small to large varices is about 20% after 
1 year period. EV bleeding is the most serious and life-
threatening complication in patients with liver cirrhosis. 
The risk of bleeding of 25-35% in a year has been 
detected. The mortality rate of each bleeding episode is 
17-57% and almost 70% patients without treatment died 
within 1 year of their first bleeding.1 The occurrence of 
bleeding may be predicted by the red sign or red cherry 
spots on the varices and by the size of varices. The risk 
of bleeding may be reduced by using non-selective 
beta blockers and endoscopic variceal ligation has been 
shown to be an effective prophylaxis, particularly against 
the first variceal bleeding.1,2 Therefore, regular screening 
by endoscopy is very recommended for patients without 
or with small-sized varices and such procedure should be 
performed in every 2 years. The American Association 
for the Study of Liver Disease recommend screening in 
all patients with cirrhosis to recognize the presence of 
EV when a diagnosis of cirrhosis is made.2 However, 
repeating endoscopy is not convenient for patients and 
it brings high-cost burden; therefore, other parameters, 
particularly the non-invasive one should be considered 
to predict the presence and the degree of EV in patients 
with liver cirrhosis. 
There are some non-invasive parameters for 
predicting the presence and the degree of EV, which 
are the biochemical, clinical and ultrasonography 
parameters. Those parameters could be performed 
separately or in combination. Among them, 
the parameters that mostly applied to predict the 
presence of EV are splenomegaly, thrombocytopenia, 
Child-Pugh score, ascites, portal flow pattern, platelet 
count-splenic size ratio, gall bladder wall thickness, 
serum ascites albumin gradient, and right lobe liver 
diameter-albumin ratio.1-10 Other parameter has also 
been used including the serum albumin level. Albumin 
itself is a part of Child-Pugh score used for predicting 
the severity of liver disease. Hypoalbuminemia in 
liver cirrhosis probably may be caused by some issues 
including decreased production that liver parenchyma 
is replaced by scar tissue, increased removal by 
the reticuloendothelial system or the spleen and 
increased albumin loss through the gastrointestinal 
system (portal hypertensive gastropathy or enteropathy), 
and all of them are associated with portal hypertension.6 
An experimental animal study demonstrated that 
portal hypertension may induce hypoalbuminemia. 
The serum albumin level increased by 20% when 
the portal vein pressure decreased after the transjugular 
intrahepatic portosystemic shunt had been performed. 
The study demonstrated that there is a correlation between 
portal hypertension and hypoalbuminemia.9 A study by 
Khan et al found that there was a significant correlation 
between serum albumin level and the presence of EV 
(r = -0.494; p < 0.01). The study was conducted in 
patients with liver cirrhosis caused by hepatitis B and 
C virus only. Serum albumin level was determined as 
< 3.5 mg/dL to predict the presence of esophageal 
varices. Moreover, a study by Sarwar et al and Schepis et 
al, found that the patient with serum albumin level < 2.95 
mg/dL may have greater probability of having EV and 
greater possibility of more severe EV.9,11 Therefore, our 
study would like to find the correlation between serum 
albumin level and the degree of EV in patients with liver 
cirrhosis.
METHOD
A retrospective analysis was performed for 
61 patients with liver cirrhosis who had their 
endoscopy procedure at Sanglah hospital between 
January and December 2008. Diagnosis of liver 
cirrhosis was established based on clinical sign 
and symptoms, appropriate laboratory results and 
ultrasonography findings. Symptoms of liver cirrhosis 
usually include swollen belly and swollen legs, fatigue, 
loss of appetite, easily sated, losing weight, epigastric 
discomfort, bloating, nausea and muscles weakness, 
abdominal pain on the right upper quadrant, black 
stool and blood vomiting. Signs of liver cirrhosis due 
to failure in liver function and clinical signs because 
of portal hypertension. Laboratory result may reveal 
anemia, signs of hypersplenism, abnormal hemostasis, 
abnormal liver function test, hypoalbuminemia, 
hyperglobulinemia, electrolyte disturbances and 
abnormal serological marker for hepatitis virus. 
Ultrasonographic study includes observation on liver 
angled edge, surface contour, homogeneity and the 
occurrence of any mass. In advanced cirrhosis, the 
ultrasonography may show a small and nodular liver, 
irregular surface contour, and increased echogenicity 
in liver parenchyma.12 
Serum albumin level was determined by a time 
endpoint method using the Synchron Cx® System. 
Basically, in the reaction the albumin was combined 
with bromcresol purple (BCP) to form a colored 
complex. The ratio used in the system was one 
part of sample to 100 parts of reagent. The system 
monitored the change in absorbance and it was directly 
proportional to the concentration of albumin in the 
sample, with chemical reaction of: albumin + BCP 
 albumin-BCP complex.13 The serum albumin level 
used in the study were albumin measurements upon 
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DISCUSSION 
Some previous studies indicated that there was 
a significant correlation between the degree of EV and 
serum ascites albumin gradient (SAAG), as well as 
with the right liver lobe diameter/albumin ratio.1-3,6,8-11 
It could be understood since both SAAG and 
the right liver lobe diameter/albumin ratio indicated 
the severity of portal hypertension. Furthermore, portal 
hypertension may cause EV; therefore any changes of 
both measurements would be correlated to the degree 
of EV. Often, there are only limited data of our patients 
so that we need an easier parameter to predict the 
occurrence and severity of EV including the serum 
albumin level. 
hospital admission and if the patients had not been 
admitted to the hospital, then we used the latest 
serum albumin level before the endoscopy was 
performed.
There are some methods to determine the degree of 
esophageal varises (EV) such as Japanese classification, 
Franchis classification or others. In our study, it was 
determined by subjective evaluation method.10 Grade 
I included small varices that were only detectable on 
performing a Valsava maneuver; grade II referred to 
small varices approximately 1-3 mm in diameter that 
were visible both during inspiration and expiration; 
grade III were varices of moderate size with 3-6 mm 
in diameter, and grade IV indicated large varices over 
6 mm. The inclusion criteria of our study were patients 
who had been confirmed to have liver cirrhosis with 
clinical signs and symptoms, laboratory results and 
suitable ultrasonographic findings and patients who 
had their esophagogastroduodenoscopy between 
January and December 2008 at Sanglah hospital, 
Denpasar. The exclusion criteria were patients with 
history of albumin transfusion prior to the EGD, 
history of sclerotherapy or band ligation treatment, 
history of treatment for portal hypertension, history 
of treatment using diuretics, had thrombosis of portal 
vein as revealed by the abdominal ultrasonography, 
who had hematemesis melena previously, who had 
infection or other abnormalities that may affect 
the serum albumin level. 
Data are presented in the form of graphs, tables, 
histogram, and scatter plot diagram. Correlation 
between serum albumin level and the degree of EV 
was determined by using Spearman test. Statistically 
significant level was considered when the value of p 
< 0.05 with CI 95%.
RESULTS
Of patients with liver cirrhosis who had the EGD, 
there were 61 eligible patients including 45 (73.8%) 
male 16 (26.2%) female patients with age ranged 
of 13–77 years and the mean age of 49.98 ± 1.621 
years. Patient characteristics and laboratory results are 
presented on Table 1. 
EGD findings revealed that EV were found in 
53 patients with varices of fundus in 24 patients and 
cardia in 2 patients; the patients without EV were 
patients with only fundal varices; while all patients 
with varices of cardia may also have the EV. There was 
a negative correlation between serum albumin level and 
the degree of EV (r = - 0.587; p = 0.000).
Table 1. Characteristic of patient 
Characteristic n (%) Mean ± SD
Sex
Male
Female
45 (73.8)
16 (26.2)
Age (years)   49.98 ± 1.62
10-19
20-29
30-39
40-49
50-59
60-69
≥ 70
1 (1.6)
2 (3.3)
14 (23.0)
15 (24.6)
15 (24.6)
13 (31.3)
1 (1.6)
Albumin (mg/dL)   2.21 ± 0.45
< 2.8
2.8-3.5
> 3.5
56 (91.8)
4 (6.6)
1 (1.6)
Degree of EV 
Without EV
Grade I
Grade II
Grade III
Grade IV
8 (13.1)
14 (23.0)
21 (34.4)
18 (29.5)
0 (0.0)
Laboratory examination
Hemoglobin (3.1-16.9 mg/dL)
Platelet (7-631 x 1,000/L) 
Serum bilirubin (0.32-26.30 mg/dL)
AST (15-1,544 IU/L)
ALT (10-947 IU/L)
9.53 ± 0.37
141.78 ± 13.98
4.03 ± 0.72
117.23 ± 27.73
81.96 ± 21.39
EV: esophageal varices; AST: aspartate aminotransferase; ALT: alanine aminotransferase
Figure 1. Scatter plot diagram of correlation between albumin 
and the degree of esophageal varices
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Albumin (50-60% of total plasma proteins), 
globulin, and fibrinogen are the greatest part of plasma 
proteins with an increase of 24-56% death risk for each 
2.5 g/dL decrement in serum albumin level. Albumin is 
an integral part of Child-Pugh score that could predict 
the severity of liver disease. Liver produces albumin as 
much as 130-200 mg/kgBW/day. There are multifactor 
mechanisms hypoalbuminemia in liver cirrhosis. 
It probably may be caused by decreased production that 
liver parenchyma is replaced by scar tissue, increased 
removal by the reticuloendothelial system or the spleen 
and increased albumin loss through the gastrointestinal 
system such as portal hypertensive gastropathy or 
enteropathy.6 Most patients in our study (91.8%) 
had serum albumin level of < 2.8 mg/dL and they 
were likely to have severe liver disease (Child Pugh 
score C). The albumin level ranged between 1.10 and 
3.60 mg/dL with the mean value of 2.21 ± 0.45 mg/dL. 
We did not performed measurement of the Child Pugh 
score due to limited financial support and considering 
that our study was a retrospective study. 
The degree of EV indicates the severity of portal 
hypertension, the higher degree of EV, the more 
severe the portal hypertension. However, the severity 
of portal hypertension does not suggest the severity 
of liver disease. In contrast, the degree of EV may be 
used to predict the probability of bleeding occurrence. 
Our study was using subjective method for criteria on 
degree of EV performed by different operator but still 
using exactly the same criteria. To predict the presence 
of EV, some previous studies have used different limits 
of albumin levels. Schepis et al and Sarwar et al, used 
limit of albumin level < 2.95 mg/dL; while Khan et al 
used < 3.5 mg/dL. All of them demonstrated significant 
correlations.6,9,11 This study did not use any certain 
limits and the correlation between EV and albumin 
was evaluated by Spearman test. A study by Khan et 
al, indicated that higher frequency of hypoalbuminemia 
above age 30 (27.4%) suggests worsening of albumin 
levels as the disease advances with growing age.6 
Bressler et al, found hypoalbuminemia of < 4 mg/dL 
as an independent risk factor for EV with odd ratio 
of 6.02.14 
In this study, we found that most patients were at 
40-59 years of age; however, there was no significant 
correlation between age and albumin level (r = -0.218, 
p = 0.091). It may be caused by different study 
population, the cause of liver disease itself, or by 
the multifactorial cause of hypoalbuminemia. 
In addition, there was no significant correlation 
between age and the degree of EV; therefore, the 
age could not be used to predict the degree of portal 
hypertension (r = 0.005; p = 0.970; p < 0.01). 
The correlation between albumin level and degree 
of EV has been demonstrated by some studies. 
Khan et al, conducted a cross-sectional prospective 
study in patients with chronic liver disease caused by 
hepatitis B and C. About 197 patients were categorized 
into 2 groups consisted of group A with albumin level 
< 3.5 mg/dl and group B with normal albumin level. 
EV was found in 63 patients. The sensitivity of albumin 
as a predictor of EV was 53.2%, the specificity was 
91%, and odds ratio was 11.57. The Spearman test 
suggested a significant negative correlation (r = -0.494) 
between serum albumin level and the degree of EV.6 
Moreover, Sarwar et al, had studied 101 patients 
with liver cirrhosis who had never have EV bleeding. 
They found that serum albumin level < 2.95 mg/dL, 
platelet counts of < 88 K/uL, and portal vein diameter 
> 11 mm were associated with the presence of EV and 
the patients were more likely to have severe degree 
of EV. 9 We conducted this study in 61 patients with 
liver cirrhosis who had fulfilled the criteria without 
considering the cause of cirrhosis. This study found 
a significant negative correlation between serum 
albumin level and the degree of EV (r = -0.587; p = 0.000; 
p < 0.01). Thus, without considering the etiology of 
liver cirrhosis, the albumin level could still be used to 
predict the degree of EV severity.
CONCLUSION
There was a negative correlation between serum 
albumin level and the degree of EV in patients with 
liver cirrhosis and therefore, the serum albumin level 
could be used as a predictor for determining the degree 
of EV. 
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